Bifogade filer
PDF
Kurs
-2,84%
Kalender
| Est. tid* | ||
| 2025-02-18 | - | Bokslutskommuniké 2024 |
| 2024-11-19 | - | Kvartalsrapport 2024-Q3 |
| 2024-08-20 | - | Kvartalsrapport 2024-Q2 |
| 2024-06-07 | - | X-dag ordinarie utdelning CALMA B 0.00 SEK |
| 2024-06-05 | - | Årsstämma |
| 2024-05-21 | - | Kvartalsrapport 2024-Q1 |
| 2024-02-20 | - | Bokslutskommuniké 2023 |
| 2023-12-14 | - | Extra Bolagsstämma 2023 |
| 2023-11-21 | - | Kvartalsrapport 2023-Q3 |
| 2023-08-22 | - | Kvartalsrapport 2023-Q2 |
| 2023-05-23 | - | Kvartalsrapport 2023-Q1 |
| 2023-05-17 | - | X-dag ordinarie utdelning CALMA B 0.00 SEK |
| 2023-05-16 | - | Årsstämma |
| 2023-02-21 | - | Bokslutskommuniké 2022 |
| 2022-11-22 | - | Kvartalsrapport 2022-Q3 |
| 2022-09-22 | - | Extra Bolagsstämma 2022 |
| 2022-08-23 | - | Kvartalsrapport 2022-Q2 |
| 2022-05-24 | - | Kvartalsrapport 2022-Q1 |
| 2022-05-19 | - | X-dag ordinarie utdelning CALMA B 0.00 SEK |
| 2022-05-17 | - | Årsstämma |
| 2022-02-25 | - | Bokslutskommuniké 2021 |
| 2022-02-23 | - | Bokslutskommuniké 2021 |
| 2021-10-29 | - | Kvartalsrapport 2021-Q3 |
| 2021-08-27 | - | Kvartalsrapport 2021-Q2 |
| 2021-05-28 | - | Kvartalsrapport 2021-Q1 |
| 2021-05-19 | - | X-dag ordinarie utdelning CALMA B 0.00 SEK |
| 2021-05-18 | - | Årsstämma |
| 2021-02-26 | - | Bokslutskommuniké 2020 |
| 2020-12-23 | - | Extra Bolagsstämma 2020 |
| 2020-11-25 | - | Kvartalsrapport 2020-Q3 |
| 2020-08-27 | - | Kvartalsrapport 2020-Q2 |
| 2020-05-20 | - | Kvartalsrapport 2020-Q1 |
| 2020-05-15 | - | X-dag ordinarie utdelning CALMA B 0.00 SEK |
| 2020-05-14 | - | Årsstämma |
| 2020-02-28 | - | Bokslutskommuniké 2019 |
| 2019-11-25 | - | Kvartalsrapport 2019-Q3 |
| 2019-11-06 | - | Extra Bolagsstämma 2019 |
| 2019-08-27 | - | Kvartalsrapport 2019-Q2 |
| 2019-05-23 | - | Kvartalsrapport 2019-Q1 |
| 2019-05-10 | - | X-dag ordinarie utdelning CALMA B 0.00 SEK |
| 2019-05-09 | - | Årsstämma |
| 2019-02-28 | - | Bokslutskommuniké 2018 |
| 2018-11-26 | - | Kvartalsrapport 2018-Q3 |
| 2018-08-27 | - | Kvartalsrapport 2018-Q2 |
Beskrivning
| Land | Sverige |
|---|---|
| Sektor | Hälsovård |
| Industri | Medicinteknik |
Calmark Sweden AB (publ) today announces a rethinking of the China strategy, in view of the current global context and the growing politicization of the Chinese business environment. The Wuxi subsidiary, which was foreseen to serve as the basis of a Joint Venture, will be dissolved; as in the rest of the world, the sales strategy in China will instead be based on distributor cooperation. Calmark's subsidiary in Hong Kong will remain, henceforth forming the hub of the Chinese market activities.
International investments in China are decreasing in favour of markets such as for example India and Vietnam. Like many other companies, Calmark is now reconsidering its planned investments in China.
Every care has been taken in the translation of this document. In the event of discrepancies, the Swedish original will supersede the English translation.
This disclosure contains information that Calmark Sweden AB is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on 20-01-2023 09:00 CET.
Camilla Arneving, Acting CEO
Telefon: +46 (0)10 204 01 50
E-post: camilla.arneving@calmark.se
www.calmark.se